Page last updated: 2024-12-10

phenylethyl 3-methylcaffeate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phenylethyl 3-methylcaffeate: a caffeic acid ester present in propolis, a natural resin produced by honey bees; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5284444
CHEMBL ID442022
SCHEMBL ID14259660
MeSH IDM0247227

Synonyms (43)

Synonym
3-(4-hydroxy-3-methoxy-phenyl)-acrylic acid phenethyl ester
bdbm50029216
(e)-3-(4-hydroxy-3-methoxy-phenyl)-acrylic acid phenethyl ester
phenethyl 3-(4-hydroxy-3-methoxyphenyl)acrylate
phenethyl (e)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate
nsc666255
.beta.-phenylethyl 4-hydroxy-3-methoxycinnamate
phenylethyl-3-methylcaffeate
2-phenylethyl (2e)-3-[4-hydroxy-3-(methyloxy)phenyl]prop-2-enoate
nsc-671193
nsc-666255
nsc671193
phenylethyl 3-methylcaffeate
2-phenylethyl 3-(4-hydroxy-3-methoxyphenyl)-2-propenoate
ccris 7791
phenyethyl 3-methylcaffeate
2-propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, 2-phenylethyl ester
CHEMBL442022 ,
caffeic acid 3-methyl phenethyl ester
AKOS015966757
b49b43355j ,
phenylethyl ferulate
3-methylcaffeic acid phenylethyl ester
unii-b49b43355j
2-phenylethyl ferulate
ferulic acid phenethyl ester
phenethyl ferulate
SCHEMBL14259660
2-phenylethyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
caffeicacid,3-methylphenethylester
DTXSID8021143
mfcd18385026
Q27464606
2-phenylethyl (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
MS-24287
CS-W009964
HY-W009248
phenethyl-trans-ferulate
beta-phenethyl ferulate
132335-98-9
2-propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, 2-phenylethyl ester, (2e)-
AKOS040760769
phenethyl (e)-3-(4-hydroxy-3-methoxyphenyl)acrylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Integrase Human immunodeficiency virus 1IC50 (µMol)100.00000.00051.544310.0000AID91430; AID91579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TransthyretinHomo sapiens (human)EC50 (µMol)7.90005.60007.54298.6000AID1169291
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID339080Toxicity in hen chorioallantoic membrane assessed as maximum tolerable concentration causing no morphological changes1992Journal of natural products, Mar, Volume: 55, Issue:3
Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids).
AID339079Antiviral activity against influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in hen chorioallantoic membrane assessed as minimum drug level causing inhibition of viral infectivity after 48 hrs1992Journal of natural products, Mar, Volume: 55, Issue:3
Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids).
AID91579Inhibitory activity against HIV-1 Integrase (HIV-1-IN)2002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
AID91430In vitro inhibitory activity against HIV-1 integrase.1995Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21
Hydroxylated aromatic inhibitors of HIV-1 integrase.
AID1169299Competitive binding to TTR V30M mutant (unknown origin) expressed in Escherichia coli at 1 to 80 uM by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1169291Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1169300Displacement of ANS from TTR V30M mutant (unknown origin) expressed in Escherichia coli at 1 to 50 uM after 5 mins by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1446872Inhibition of recombinant HIV-1 group M subtype B RT-RNase H activity expressed in Escherichia coli M15 using 18-nucleotide 3'-fluorescein-labeled RNA annealed to a complementary 18-nucleotide 5'-dabsyl-labeled DNA as substrate measured after 1 hr2017European journal of medicinal chemistry, Apr-21, Volume: 130Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase.
AID1169294Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation at 20 uM by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1718341Growth inhibition of human KMM-1 cells at 10 uM after 48 hrs by PrestoBlue cell viability assay relative to control2020Journal of natural products, 12-24, Volume: 83, Issue:12
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.
AID1446873Inhibition of wild-type HIV1 RT associated RNA dependent DNA polymerase activity using poly(A) template/oligo(dT) primer after 30 mins by picogreen staining based method2017European journal of medicinal chemistry, Apr-21, Volume: 130Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase.
AID1169301Inhibition of acid-mediated dissociation of TTR V30M mutant (unknown origin) expressed in Escherichia coli after 30 mins by SDS-PAGE2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID339078Antiviral activity against influenza A virus (A/Hong Kong/1/1968(H3N2)) infected in hen chorioallantoic membrane assessed as minimum drug level causing inhibition of viral infectivity after 48 hrs1992Journal of natural products, Mar, Volume: 55, Issue:3
Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids).
AID1524671Covalent inhibition of purified Sporosarcinia pasteurii urease by phenol red based method
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's2 (20.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]